The goal of the proposed research is to determine the site and mechanism of action of botulinum toxin. This goal will be pursued by focusing on three areas of research closely related to current knowledge on the structure and function of the toxin molecule. Botulinum toxin acts on cholinergic nerve endings to block transmitter release. To exert this action, the toxin proceeds through a sequence of three steps: 1.) a membrane binding step, 2.) an internalization step, and 3.) an intracellular poisoning step. The precise mechanism of intracellular poisoning remains unknown, but the extraordinary potency of the molecule suggests that it is an enzyme. The proposed model for botulinum toxin action was developed on murine preparations (phrenic nerve hemidiaphragm), and it has been partially confirmed on other laboratory animal preparations (e.g., PC-12 cells, adrenal chromaffin cells, pituitary cells). However, botulinum toxin action has never been studied on isolated human neuromuscular junctions. Therefore, the first task of the proposed research will be to determine the sequence of events involved in poisoning of human tissues. Evidence from laboratory animal studies indicates that botulinum toxin acts inside cells to block exocytosis. It is anticipated that the same result will be obtained with human cells. However, there are no data that identify the specific domain within the toxin molecule that is responsible for intracellular poisoning. Therefore, the second task of the proposed research will be to identify a specific polypeptide that blocks exocytosis. There is a prevailing belief that botulinum toxin is an enzyme, and thus that it catalytically modifies a substrate essential for transmitter release. However, neither the location of the substrate nor its role in exocytosis has been determined. Therefore, the final task of the proposed research will be to identify an intracellular target molecule that interacts with, or is enzymatically modified by, botulinum toxin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS022153-11
Application #
2264399
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1984-09-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Xu, Q; Pichichero, M E; Simpson, L L et al. (2009) An adenoviral vector-based mucosal vaccine is effective in protection against botulism. Gene Ther 16:367-75
Ravichandran, Easwaran; Al-Saleem, Fetweh H; Ancharski, Denise M et al. (2007) Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect Immun 75:3043-54
Zeng, Mingtao; Xu, Qingfu; Elias, Md et al. (2007) Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine. Vaccine 25:7540-8
Ravichandran, Easwaran; Gong, Yujing; Al Saleem, Fetweh H et al. (2006) An initial assessment of the systemic pharmacokinetics of botulinum toxin. J Pharmacol Exp Ther 318:1343-51
Ahsan, Chowdhury R; Hajnoczky, Gyorgy; Maksymowych, Andrew B et al. (2005) Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells. J Pharmacol Exp Ther 315:1028-35
Maksymowych, Andrew B; Simpson, Lance L (2004) Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells. J Pharmacol Exp Ther 310:633-41
Simpson, Lance L; Maksymowych, Andrew B; Park, Jong-Beak et al. (2004) The role of the interchain disulfide bond in governing the pharmacological actions of botulinum toxin. J Pharmacol Exp Ther 308:857-64
Park, Jong-Beak; Simpson, Lance L (2003) Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component. Infect Immun 71:1147-54
Park, Jong-Beak; Simpson, Lance L; Anderson, Timothy D et al. (2003) Immunologic characterization of spasmodic dysphonia patients who develop resistance to botulinum toxin. J Voice 17:255-64
Simpson, L L; Maksymowych, A B; Hao, S (2001) The role of zinc binding in the biological activity of botulinum toxin. J Biol Chem 276:27034-41

Showing the most recent 10 out of 42 publications